Image

GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites

Study on Investigational Medication for Advanced Gastrointestinal Cancer with Malignant Ascites

Recruiting
20 years and older
All
Phase 1/2

This study investigates advanced gastrointestinal cancer of microsatellite stable with malignant ascites. The purpose of this study is to understand the effects of an investigational medication alone or combined with another treatment.

The study evaluates the safety and effectiveness of the investigational medication. It focuses on understanding how well the medication works and its safety when used by patients with this specific type of cancer.

  • Who can participate: Adults aged 20 years or older with advanced gastric or pancreatic cancer that has spread and cannot be removed by surgery can participate. Participants should have tried previous treatments but found them ineffective.
  • Study details: Participants will receive the investigational medication either alone or with another treatment. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
Study details
    Gastric Cancer
    Pancreatic Cancer

NCT05438459

Kyushu University

30 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.